DNU Lifestyle

Study: Bladder cancer drug extends survival

Study: Bladder cancer drug extends survival

Bristol Myers Squibb Co said on Tuesday its blockbuster cancer immunotherapy, Opdivo, in combination with chemotherapy improved survival in patients with a type of bladder cancer in a late-stage trial...

Archive·